{"ok":true,"entity":{"id":"eli-lilly","name":"Eli Lilly","entityType":"company","officialName":"Eli Lilly and Company","canonicalName":"Eli Lilly","displayName":"Eli Lilly","category":"大手製薬企業","shortDescription":"1876年創業、米国インディアナ州インディアナポリスに本社を置く製薬企業。糖尿病・肥満症などの代謝疾患、腫瘍、免疫疾患、神経科学を重点領域とする。tirzepatide（Mounjaro／Zepbound）を中心とするインクレチン関連製品の急成長により、近年売上規模を大きく拡大させている。","primaryCluster":"pharmaceuticals","parentEntity":null,"verificationStatus":"draft","website":"https://www.lilly.com","updatedAt":"2026-08-06T01:18:46.240Z","secondaryClusters":[],"alias":["Lilly"],"searchKeywords":["GLP-1","代謝疾患","腫瘍","神経科学","Mounjaro","Zepbound"]},"referenceIndex":["P-01-001","P-02-001","P-04-001","P-06-001","P-04-002"]}